Discover

NRXP
NRx Pharmaceuticals, Inc.
3.86
2 x 2.95
2 x 5.01
bid
ask
-
0.23
5.62%
2 @ 04:00 PM
3.90 +0.04 (1.04%)
Ytd42.44%
1y16.27%
3.84
day range
4.10
1.62
52 week range
5.05
Open4.07Prev Close4.09Low3.84High4.10Mkt Cap165.21M
Vol643.90KAvg Vol1.28MEPS-1.04P/EN/AForward P/E-1.12
Beta1.27Short Ratio4.80Inst. Own6.05%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1450-d Avg3.55200-d Avg2.701yr Est31.67

NRXP News

benzinga.com
NRx Pharmaceuticals Issues Statement In Response To Kadima Allegations, Citing Arbitration Over Non‑

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) ("NRx" or the "Company") today issued the fo

NRx Pharmaceuticals Responds to Recent Public Statements Regarding Kadima Dispute
globenewswire.com
NRx Pharmaceuticals Responds to Recent Public Statements Regarding Kadima Dispute

WILMINGTON, Del., June 25, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx”

benzinga.com
NRx Pharma’s HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navi

First Zeta-navigated TMS treatments have begun at HOPE Therapeutics clinics in West Palm Beach and S

NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System
globenewswire.com
NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Sur

First Zeta-navigated TMS treatments have begun at HOPE Therapeutics clinics in West Palm Beach and S

benzinga.com
NRx Pharma Announces FDA Approval Of Intermediate Population Expanded Access Protocol For Use Of NRX

D-Cycloserine (DCS) has been reported to augment the effect of Transcranial Magnetic Stimulation (TM

benzinga.com
NRx Pharmaceuticals Prices $20M Public Offering Of 5,714,286 Shares Of Common Stock At A Price Of $3

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) ("NRx Pharmaceuticals" or the "Company"), a

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Why Tetra Technologies Shares Are Trading Lower By Over 15%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Tetra Technologies Shares Are Trading Lower By Over 15%; Here Are 20 Stocks Moving Premarket

Tetra Technologies Inc. (NYSE: TTI) shares fell 15.06% in pre-market trading after announcing a $100

NRx Pharmaceuticals (NRXP) Stock Fell 19% After Hours On Tuesday: Here's Why
benzinga.com
NRx Pharmaceuticals (NRXP) Stock Fell 19% After Hours On Tuesday: Here's Why

NRXP stock fell after hours after NRx Pharmaceuticals announced a public stock offering to raise cap

12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

benzinga.com
NRx Pharmaceuticals Announces Proposed Underwritten Public Offering Of Common Stock; No Terms Disclo

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) ("NRx Pharmaceuticals" or the "Company"), a

benzinga.com
NRx Pharma's Strategic Partner, Emobot Health, Presents Late-Breaking Poster At 2026 Annual Meeting

EMOCARE is a smartphone-based passive monitoring tool that generates a continuous, real-time measure

benzinga.com
NRx Pharma's HOPE Unit Deploys Zeta Surgical's FDA‑Cleared TMS Navigation System At West Palm Beach

Deployment at HOPE's West Palm Beach clinic brings AI-powered, sub-millimetric image guidance to

12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

benzinga.com
NRx Pharma Targets FDA Approvals, Expands Clinics And Advances PTSD Drug Pipeline In 2026

Key highlights from the first quarter of operations under the expanded management team include the f

benzinga.com
NRX Pharmaceuticals Q1 EPS $(0.04) Up From $(0.34) YoY, Sales $1.068M

NRX Pharmaceuticals (NASDAQ:NRXP) reported quarterly losses of $(0.04) per share. This is a 88.24 pe

NRx Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
benzinga.com
NRx Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Ea

NRx Pharma (NRXP) set to release Q1 earnings on May 18. Analysts expect $19.43 million in revenue, w

benzinga.com
NRx Pharma Receives Clearance From FDA To Initiate Clinical Trial Of NRX-101 Vs. Placebo In Patients

Preliminary research suggests that D-cycloserine significantly enhances the effect of Transcranial M

benzinga.com
NRx Starts Production Of Preservative-Free Ketamine Ahead Of FDA Decision, Expands Manufacturing, Bu

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP), a biopharmaceutical company that focuses on neuroplastic th

benzinga.com
HC Wainwright & Co. Reiterates Buy on NRX Pharmaceuticals, Maintains $45 Price Target

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates NRX Pharmaceuticals (NASDAQ:NRXP)

benzinga.com
Ascendiant Capital Maintains Buy on NRX Pharmaceuticals, Raises Price Target to $49

Ascendiant Capital analyst Edward Woo maintains NRX Pharmaceuticals (NASDAQ:NRXP) with a Buy and

benzinga.com
NRx Pharmaceuticals Welcomes The Newly-Signed Presidential Executive Order: Accelerating Medical Tre

In the Order, the President notes that, "It is the policy of my Administration to accelerate inn

benzinga.com
NRx Pharmaceuticals Receives FDA Letter Regarding Comments On Minor Formatting Changes To Proposed L

NRx has received a letter from the FDA Office of Generic Drugs indicating preliminary alignment on l

benzinga.com
BTIG Reiterates Buy on NRX Pharmaceuticals, Maintains $25 Price Target

BTIG analyst Thomas Shrader reiterates NRX Pharmaceuticals (NASDAQ:NRXP) with a Buy and maintains

benzinga.com
NRX Pharmaceuticals Q4 EPS $0.20 Up From $(0.77) YoY, Sales $983.000K

NRX Pharmaceuticals (NASDAQ:NRXP) reported quarterly earnings of $0.20 per share. This is a 125.97 p

NRx Pharma Stock Jumps After FDA Signals Path To NDA For Ketamine Depression Drug
benzinga.com
NRx Pharma Stock Jumps After FDA Signals Path To NDA For Ketamine Depression Drug

The FDA signals its willingness to review NRx Pharmaceuticals' NRX-100 NDA, boosting optimism ar

benzinga.com
NRx Pharmaceuticals Intends To Submit New Drug Application For NRX-100 By June Following Successful

NRXP has received confirmatory minutes from an in-person Type C guidance meeting at the headquarters

benzinga.com
NRx Pharmaceuticals' HOPE Therapeutics Expands Clinic Network With Palm Beach Location Targeting Dep

Published results have shown 87% clinical response to non-invasive Transcranial Magnetic Stimulation

benzinga.com
HC Wainwright & Co. Maintains Buy on NRX Pharmaceuticals, Raises Price Target to $45

HC Wainwright & Co. analyst Patrick R. Trucchio maintains NRX Pharmaceuticals (NASDAQ:NRXP) w

benzinga.com
BTIG Reiterates Buy on NRX Pharmaceuticals, Maintains $25 Price Target

BTIG analyst Thomas Shrader reiterates NRX Pharmaceuticals (NASDAQ:NRXP) with a Buy and maintains

benzinga.com
D. Boral Capital Maintains Buy on NRX Pharmaceuticals, Maintains $34 Price Target

D. Boral Capital analyst Jason Kolbert maintains NRX Pharmaceuticals (NASDAQ:NRXP) with a Buy and

benzinga.com
BTIG Reiterates Buy on NRX Pharmaceuticals, Maintains $25 Price Target

BTIG analyst Thomas Shrader reiterates NRX Pharmaceuticals (NASDAQ:NRXP) with a Buy and maintains

12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

benzinga.com
NRx Uses Real-World Ketamine Data to Seek Faster FDA Approval for Suicide Treatment

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP), a clinical-stage biopharmaceutical company, today announced

benzinga.com
D. Boral Capital Maintains Buy on NRX Pharmaceuticals, Maintains $34 Price Target

D. Boral Capital analyst Jason Kolbert maintains NRX Pharmaceuticals (NASDAQ:NRXP) with a Buy and

Ulta Beauty To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday
benzinga.com
Ulta Beauty To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday

benzinga.com
Ascendiant Capital Maintains Buy on NRX Pharmaceuticals, Raises Price Target to $48

Ascendiant Capital analyst Edward Woo maintains NRX Pharmaceuticals (NASDAQ:NRXP) with a Buy and

benzinga.com
NRx Pharmaceuticals Repays Remaining $5.4M Balance Sheet Debt To Anson Funds Through Equity Conversi

Remaining $5.4 million debt was repaid through strategic equity conversion in common stock with no a

benzinga.com
HC Wainwright & Co. Reiterates Buy on NRX Pharmaceuticals, Maintains $40 Price Target

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates NRX Pharmaceuticals (NASDAQ:NRXP)

benzinga.com
D. Boral Capital Maintains Buy on NRX Pharmaceuticals, Maintains $34 Price Target

D. Boral Capital analyst Jason Kolbert maintains NRX Pharmaceuticals (NASDAQ:NRXP) with a Buy and

benzinga.com
NRx Pharma Pursues "One-Day" Depression Treatment That Could Be Twice as Effective as Standard Pills

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP), a clinical-stage biopharmaceutical company, today announced

benzinga.com
BTIG Reiterates Buy on NRX Pharmaceuticals, Maintains $25 Price Target

BTIG analyst Thomas Shrader reiterates NRX Pharmaceuticals (NASDAQ:NRXP) with a Buy and maintains

benzinga.com
D. Boral Capital Maintains Buy on NRX Pharmaceuticals, Maintains $34 Price Target

D. Boral Capital analyst Jason Kolbert maintains NRX Pharmaceuticals (NASDAQ:NRXP) with a Buy and

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session

benzinga.com
D. Boral Capital Maintains Buy on NRX Pharmaceuticals, Maintains $34 Price Target

D. Boral Capital analyst Jason Kolbert maintains NRX Pharmaceuticals (NASDAQ:NRXP) with a Buy and

Earnings Scheduled For November 17, 2025
benzinga.com
Earnings Scheduled For November 17, 2025

Earnings Outlook For NRX Pharmaceuticals
benzinga.com
Earnings Outlook For NRX Pharmaceuticals

benzinga.com
D. Boral Capital Maintains Buy on NRX Pharmaceuticals, Maintains $34 Price Target

D. Boral Capital analyst Jason Kolbert maintains NRX Pharmaceuticals (NASDAQ:NRXP) with a Buy and

benzinga.com
HOPE Therapeutics Launches First-in-Florida Deployment Of Ampa ONE-D Protocol, Achieving Single-Day

ONE-D is the first reported protocol to achieve remission from treatment-resistant depression with a

Alphabet To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Thursday
benzinga.com
Alphabet To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Thursday